The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information

The National Cancer Institute has awarded USC scientists $3.5 million for a study of the enzyme that faithfully copies our genetic information, enabling it to pass from one generation to the next.

The grant will fund structural, biochemical and computer studies designed to reveal how the enzyme, DNA polymerase, makes so few mistakes.

"This is a unique opportunity to marry theory and experiment in molecular and computational chemical biology," said principal investigator Myron Goodman, professor of biological sciences and chemistry in the USC College of Letters, Arts and Sciences.

"We're asking questions that can't be asked without theoretical tools, and they can't be answered without experimental and structural work," said Arieh Warshel, professor of chemistry, who will lead the theoretical part of the project and guide the modeling of the enzyme's activity using sophisticated computer software he's developed.

When a cell divides, DNA polymerase copies the cell's DNA, using the sequence of DNA bases, the strong affinity between bases (A pairs with T; C with G), and, most importantly, the enzyme's exquisite catalytic selectivity, to add the correct base to the growing strand.

The enzyme adds the wrong, mismatched DNA base only once in every 10,000 to one million bases. Further proofreading drops the overall error rate to one in a billion-about six mistakes per cell division.

Most of these mutations are benign or neutral, but some may lead to cancer.

"The question is how the enzyme knows when it's got the correct DNA base versus the incorrect one, and how that changes the speed of the reaction," Warshel said.

A third project led by structural biologist Samuel Wilson, deputy director of the National Institute of Environmental Health Sciences, will provide detailed 3-D "snapshots" of the enzyme.

Based on the snapshots, Warshel's studies will lead to specific predictions, which Goodman's team will test in the lab and then provide feedback on the model. Once the model is perfected, all three groups will study altered versions of the enzyme to identify activities essential to its accuracy.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Machine learning model predicts CDK4/6 inhibitor effectiveness in metastatic breast cancer